The University at Buffalo School of Pharmacy and Pharmaceutical Sciences has won a $12 million award from the National Institutes of Health to ensure the quality of clinical research into HIV, AIDS and infectious diseases conducted around the world.
The Clinical and Pharmacology Quality Assurance, or CPQA, contract runs for seven years and is a competitive renewal of an initial UB contract that began in 2008 and concluded this year.
The UB researchers will provide quality assurance on clinical pharmacology research, including the prevention and eradication of HIV, antiretroviral treatment strategies, development of viral hepatitis drugs and treatment of tuberculosis and related diseases.
The UB program coordinates important pieces of the research, provides training for scientists involved in the studies, conducts on-site laboratory visits, ensures the sharing of relevant data and supports a centralized website.
The principal investigator on the grant is Gene D. Morse, SUNY Distinguished Professor at UB and associate director of UB’s New York State Center of Excellence in Bioinformatics and Life Sciences.